During the past decade, Berks Schuylkill Respiratory Specialists, Ltd. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berks Schuylkill Respiratory Specialists, Ltd." #1 sponsor was "Actelion" with 1 trials, followed by "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Mallinckrodt" with 1 trials sponsored and "United Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Berks Schuylkill Respiratory Specialists, Ltd." are "Asthma" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Sarcoidosis, Pulmonary" (1 trials). Many other conditions were trialed in "Berks Schuylkill Respiratory Specialists, Ltd." in a lesser frequency.

Most popular intervention types in "Berks Schuylkill Respiratory Specialists, Ltd." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acthar Gel" (1 trials), "FP" (1 trials), "GB001" (1 trials) and "LABA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berks Schuylkill Respiratory Specialists, Ltd." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Berks Schuylkill Respiratory Specialists, Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Berks Schuylkill Respiratory Specialists, Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Berks Schuylkill Respiratory Specialists, Ltd., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".